enGene Therapeutics Inc. (ENGN) Operating income 2022–2025
enGene Therapeutics Inc. (ENGN) annual operating income history from SEC filings — each fiscal year as reported.
-$123.2MFY2025 · since FY2022: -$19.4M → -$123.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$123.2M | -97.7% |
| FY2024 | -$62.3M | -139.1% |
| FY2023 | -$26.1M | -34.1% |
| FY2022 | -$19.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ENGN financial trends
ENGN RevenueENGN Net incomeENGN Net marginENGN Gross profitENGN Gross marginENGN Operating marginENGN Operating cash flowENGN Free cash flowENGN Capital expendituresENGN Return on equityENGN Stock buybacksENGN Dividends paidENGN Total assetsENGN Total liabilitiesENGN Shareholders’ equityENGN overview →